Who is sponsoring NCT07110961?

NCT07110961 is sponsored by Siriraj Hospital.

What drugs are being tested in NCT07110961?

Interventions in NCT07110961: A suggested immobilization test (SIT).

What condition does NCT07110961 study?

NCT07110961 studies Restless Leg Syndrome.

Is NCT07110961 still recruiting?

NCT07110961 is currently recruiting now. Last updated 13 February 2026.

Last reviewed 2026-02-13 · How we verify

NCT07110961

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Suggested Immobilization Test With Exploratory Heart Rate Variability Analysis for Diagnosis of Restless Legs Syndrome

Recruiting now NA Last updated 13 February 2026

What this trial tests

NA trial testing A suggested immobilization test (SIT) in Restless Leg Syndrome in 52 participants. Currently enrolling.

Timeline

1 October 2025

Primary endpoint
30 September 2026

31 December 2026

Quick facts

Lead sponsor	Siriraj Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	52
Start date	1 October 2025
Primary completion	30 September 2026
Estimated completion	31 December 2026
Sites	1 location across Thailand

Drugs / interventions tested

A suggested immobilization test (SIT)

Conditions studied

Restless Leg Syndrome — all drugs for Restless Leg Syndrome →

Sponsor

Siriraj Hospital

Who can join

Adults 18 to 70, any sex, with Restless Leg Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Restless leg syndrome (RLS) is not uncommon and can also affect people's health and quality of life. Mainly, RLS is diagnosed based on clinical criteria subjectively. Sometimes it is difficult to differentiate between RLS and mimickers, especially in patients with comorbidities such as diabetes or parkinson's disease. We believe that using objective tests would facilitate accuracy in RLS diagnosis, which leads to proper management of patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Siriraj Hospital trials

Trials by the same sponsor.

NCT07262034 — The Impact of Preoperative Nutrition Intervention on Muscle Mass Preserve in Older Adults Undergoing Elective Surgery · not yet recruiting
NCT07402486 — A Phase II Prospective Study of Maastro Applicator Brachytherapy for Rectal Cancer · Phase 2 · not yet recruiting
NCT07298577 — Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ult · NA · not yet recruiting
NCT07239908 — Resuscitation Enhancement to Avoid Rearrest Through Evidence-based Strategies in Prehospital Post-resuscitation Care · Phase 2, PHASE3 · not yet recruiting
NCT07125859 — Malnutrition Prevalence and Nutritional Change After Preoperative Nutrition Counseling · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07110961 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Siriraj Hospital
Last refreshed: 13 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07110961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing